Mohan Vallipuram Email

Regulatory Affairs Manager . Acrux

Current Roles

Employees:
102
Revenue:
$20.5M
About
Acrux (ASX: ACR) is a pharmaceutical company dedicated to developing and commercialising specialty and generic topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised through licensees a number of pharmaceutical products in the US and Europe using the Patchless PatchTM, a fast-drying and invisible topical application technology. Marketed products include Axiron®, Evamist® and Lenzetto®. More recently, in addition to specialty products, Acrux has identified and initiated development of a range of generic products. Acrux is leveraging its on-site laboratories, GMP manufacturing suite, clinical and commercial experience to bring more products to market. Acrux encourages collaboration and is well positioned to discuss partnering and product development.
Acrux Address
103-113 Stanley St
Melbourne, null
Acrux Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.